Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

FORGOTTEN HISTORY: What to expect from solventum s q2 2025 earnings report - Caught on Camera

Solventum Corporation (SOLV), based in Maplewood, Minnesota, is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs. With a market cap of $12.6 billion,  the company’s broad portfolio of solutions leverages material and data science, clinical research, and digital capabilities. Solventum operates in the areas of separation and purification, health information, medical solutions, medical device components, and the oral care market. The leading global healthcare company is expected to announce its fiscal second-quarter earnings for 2025 after the market closes on Thursday, Aug. 7. 

Ahead of the event, analysts expect SOLV to report a profit of $1.45 per share on a diluted basis, down 7.1% from $1.56 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.